Processa Pharmaceuticals, Inc.

Form DEF 14A Processa Pharmaceuticals Inc For: 22 October By Investing.com
Investing.com India · 23 Oct 2026
Processa Pharmaceuticals Proposes Reverse Stock Split Following Merger with Vidya Therapeutics
Kalkine Media · 09 Oct 2026
Processa Pharmaceuticals files prospectus for 306.574M share sale
scanx.trade · 09 Oct 2026
Selling stockholders would receive resale proceeds, with none going to Processa (Nasdaq: PCSA).
Stock Titan · 09 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.